A Study to Investigate the Pharmacokinetics and Safety of PKN605 in Participants With Moderate and Severe Renal Impairment Compared to Matched Control Subjects With Normal Renal Function

Authors
Category Primary study
Registry of TrialsClinicalTrials.gov
Year 2026
The purpose of this trial is to assess any potential exposure increases of PKN605 in participants with reduced renal function to support decisions on participant eligibility and dosing in subsequent clinical trials of PKN605.
Epistemonikos ID: fb7549ae2070ea8485990697f01f1f2fa4a8fcdd
First added on: Sep 01, 2026